Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients – Early Results of a Phase II Trial

Glioblastoma Multiforme (GBM) is an aggressive primary brain neoplasm with dismal prognosis. Based on successful phase III trials, 60 Gy involved-field radiotherapy in 30 fractions over 6 weeks [Standard radiation therapy (RT)] with concurrent and adjuvant temozolomide is currently the standard of c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Floyd, Scott R., Kasper, Ekkehard M., Uhlmann, Erik J., Fonkem, Ekokobe, Wong, Eric T., Mahadevan, Anand
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2012
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472503/
https://ncbi.nlm.nih.gov/pubmed/23087896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2012.00122
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars